Yangshan Chen

751 total citations
17 papers, 454 citations indexed

About

Yangshan Chen is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Yangshan Chen has authored 17 papers receiving a total of 454 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Cancer Research and 6 papers in Oncology. Recurrent topics in Yangshan Chen's work include Peptidase Inhibition and Analysis (3 papers), Cancer-related molecular mechanisms research (3 papers) and Radiomics and Machine Learning in Medical Imaging (2 papers). Yangshan Chen is often cited by papers focused on Peptidase Inhibition and Analysis (3 papers), Cancer-related molecular mechanisms research (3 papers) and Radiomics and Machine Learning in Medical Imaging (2 papers). Yangshan Chen collaborates with scholars based in China, United States and Canada. Yangshan Chen's co-authors include Zunfu Ke, Neng Jiang, Wenting Jiang, Yiyan Lei, Kejing Tang, Shuhua Li, Yongmei Cui, Yifeng Luo, Minglei Yang and Leilei Huang and has published in prestigious journals such as Nature Communications, Cellular and Molecular Life Sciences and Cell Death and Disease.

In The Last Decade

Yangshan Chen

16 papers receiving 451 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yangshan Chen China 11 200 167 146 106 85 17 454
Hyun Min Koh South Korea 12 200 1.0× 97 0.6× 89 0.6× 125 1.2× 51 0.6× 41 427
Mengwan Wu China 11 148 0.7× 184 1.1× 90 0.6× 77 0.7× 71 0.8× 19 415
Íris Sawazaki‐Calone Brazil 12 133 0.7× 159 1.0× 99 0.7× 48 0.5× 115 1.4× 14 509
Amr H. Allam Australia 10 193 1.0× 173 1.0× 110 0.8× 57 0.5× 29 0.3× 15 423
Dragica Nikolić‐Vukosavljević Serbia 14 244 1.2× 264 1.6× 106 0.7× 72 0.7× 89 1.0× 51 510
Thierry Pécot United States 13 262 1.3× 131 0.8× 100 0.7× 46 0.4× 63 0.7× 34 502
Jiarui Jiang China 11 208 1.0× 77 0.5× 185 1.3× 65 0.6× 96 1.1× 11 399
Mervi Jumppanen Finland 4 211 1.1× 215 1.3× 180 1.2× 64 0.6× 87 1.0× 5 555
Hamza Lasla France 8 304 1.5× 232 1.4× 220 1.5× 175 1.7× 42 0.5× 13 592
Zahra Mohammed United Kingdom 12 243 1.2× 283 1.7× 208 1.4× 70 0.7× 54 0.6× 18 619

Countries citing papers authored by Yangshan Chen

Since Specialization
Citations

This map shows the geographic impact of Yangshan Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yangshan Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yangshan Chen more than expected).

Fields of papers citing papers by Yangshan Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yangshan Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yangshan Chen. The network helps show where Yangshan Chen may publish in the future.

Co-authorship network of co-authors of Yangshan Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Yangshan Chen. A scholar is included among the top collaborators of Yangshan Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yangshan Chen. Yangshan Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Chen, Yangshan, Wei Pang, Guixing Ma, et al.. (2025). March5-mediated Trim28 degradation preserves islet β-cell function in mice. Nature Communications. 16(1). 7073–7073.
2.
Zhou, Bo, Zhen Ding, Yangshan Chen, et al.. (2025). Unveiling two distinct osteolineage cell populations linked to age-related osteoporosis in adult mice through integrative single-cell analyses. Cellular and Molecular Life Sciences. 82(1). 106–106. 1 indexed citations
3.
Ding, Zhen, Guixing Ma, Bo Zhou, et al.. (2024). Targeting miR-29 mitigates skeletal senescence and bolsters therapeutic potential of mesenchymal stromal cells. Cell Reports Medicine. 5(8). 101665–101665. 15 indexed citations
4.
Chen, Yangshan, Bo Zhou, Wanze Tang, et al.. (2023). Talin-1 inhibits Smurf1-mediated Stat3 degradation to modulate β-cell proliferation and mass in mice. Cell Death and Disease. 14(10). 709–709. 3 indexed citations
5.
Dong, Yuechao, Yangshan Chen, Guixing Ma, & Huiling Cao. (2023). The role of E3 ubiquitin ligases in bone homeostasis and related diseases. Acta Pharmaceutica Sinica B. 13(10). 3963–3987. 10 indexed citations
6.
Dong, Yuechao, Guixing Ma, Yingying Han, et al.. (2023). Kindlin-2 controls angiogenesis through modulating Notch1 signaling. Cellular and Molecular Life Sciences. 80(8). 223–223. 6 indexed citations
7.
Chen, Yanyang, Huan Yang, Zhiqiang Cheng, et al.. (2022). A whole-slide image (WSI)-based immunohistochemical feature prediction system improves the subtyping of lung cancer. Lung Cancer. 165. 18–27. 17 indexed citations
8.
Yang, Huan, Lili Chen, Zhiqiang Cheng, et al.. (2021). Deep learning-based six-type classifier for lung cancer and mimics from histopathological whole slide images: a retrospective study. BMC Medicine. 19(1). 80–80. 88 indexed citations
9.
Sun, Yu, Yangshan Chen, Ji Cui, et al.. (2020). Combined evaluation of the expression status of CD155 and TIGIT plays an important role in the prognosis of LUAD (lung adenocarcinoma). International Immunopharmacology. 80. 106198–106198. 80 indexed citations
10.
11.
12.
Chen, Yangshan, Yu Sun, Yongmei Cui, et al.. (2019). High CTHRC1 expression may be closely associated with angiogenesis and indicates poor prognosis in lung adenocarcinoma patients. Cancer Cell International. 19(1). 318–318. 15 indexed citations
13.
Jiang, Wenting, Han Wang, Yongmei Cui, et al.. (2018). Polymer nanofiber-based microchips for EGFR mutation analysis of circulating tumor cells in lung adenocarcinoma. International Journal of Nanomedicine. Volume 13. 1633–1642. 14 indexed citations
14.
Mao, Xiaopeng, Shuhua Li, Jianwen Zhou, et al.. (2018). Auxiliary diagnostic value of p16 amplification combined with the detection of heterozygous and homozygous loss for urothelial carcinoma. Oncology Letters. 15(5). 6533–6540. 2 indexed citations
15.
Tang, Kejing, Neng Jiang, Yukun Kuang, et al.. (2018). Overcoming T790M mutant small cell lung cancer with the third‐generation EGFR‐TKI osimertinib. Thoracic Cancer. 10(2). 359–364. 13 indexed citations
16.
He, Weiling, Hui Zhang, Yuefeng Wang, et al.. (2018). CTHRC1 induces non-small cell lung cancer (NSCLC) invasion through upregulating MMP-7/MMP-9. BMC Cancer. 18(1). 54 indexed citations
17.
Sun, Yu, Yangshan Chen, Shuhua Li, et al.. (2017). NanoVelcro-captured CTC number concomitant with enhanced serum levels of MMP7 and MMP9 enables accurate prediction of metastasis and poor prognosis in patients with lung adenocarcinoma. International Journal of Nanomedicine. Volume 12. 6399–6412. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026